S&P 500 Analysis: Index Goes on a Sudden Up-and-Down Journey: Where Is Next?


North America’s corporate giants have for a very long time been regarded as traditional, long-term investment prospects. A look at the top 500 companies in the United States in the pre-digital age would have demonstrated long periods of very little movement whatsoever.

However, gone are the days in which the upper echelons of New York’s stock exchange are represented by traditional industrial giants in the construction, commercial real estate and manufacturing sectors, with many top firms now at the forefront of science and technology.

The big movers today are often developers of pharmaceutical products and highly capitalised technology firms in Silicon Valley.

Whilst the shorter development times, quick journeys from startup to multi-billion dollar unicorn are more common than ever these days, and unlike the legacy businesses which now languish behind the tech giants, they are susceptible to greater levels of volatility.

A major construction company which just completed the building of a vast business park which will stand for over 100 years is going to be less volatile than a 10-year-old high-tech firm with a SPAC listing on NASDAQ, for example. Thus, the traditional stalwarts are still there, but the added volatility has come from the top-level tech and science firms.

The S&P 500 has been displaying such volatility recently.

Indicative pricing only

On Wednesday last week, the S&P 500 index was in a buoyant position, at 4,446 points by 15:30 during the New York trading session.

By Thursday at 11:00, it had dropped to 4,398 points which is the lowest point in over a month, before suddenly climbing back.

By Friday at 13:00 during the New York trading session, the S&P500 had regained its losses and was back to 4,440 points, almost placing it at the same value as Thursday's high point before its big drop on Wednesday.

What events will affect the market going forward?

Why is there so much sudden movement and uncertainty?

There has been some commentary and opinion as this trading week starts, ahead of the opening bell in New York today, which implies that Pfizer stock is 'oversold.' Pfizer has had an easy run over the past few years. It is not often that a product made by a commercial entity is purchased in bulk by governments across the West and then made almost mandatory.

However, those days are gone, and Pfizer is still a dominant feature within US publicly listed firms. Is it oversold? Perhaps some degree of conservatism is now stepping in.

Other more tangible reasons could be related to forthcoming earnings with traditional components such as delivery and courier giant FedEx and oil industry stalwart Exxon Mobil bolstering market sentiment alongside multinational sportswear manufacturer Nike Inc after increases in stock value which came about in the first half of the year.

There is some degree of negative sentiment around this earnings season within the US and a possibility that interest rates will be increased once again despite inflation in the US being under control.

These are interesting underlying potential factors, and the S&P500's sudden volatility over the past few days is worth keeping an eye on.

Trade global indices with zero commission and tight spreads with the Innovative Broker of 2022*. Open your FXOpen account now or learn more about trading index CFDs with FXOpen.

* FXOpen International, best ECN broker of 2022, according to the IAFT

This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.

Latest from Indices

Market Analysis: S&P 500 Falls amid News from the Fed FTSE 100 Analysis: London Out of the Doldrums! FTSE 100 Has a Day of Volatility Market Analysis: Nikkei 225 Reaches Psychological Level at 33,000 Britain's Economy: Balancing Act Amidst Gloomy Metrics and Resilient FTSE 100 Hang Seng Index Analysis: Price Recovers from Year's Low

Latest articles

Forex Analysis

Market Analysis: American Currency Rises Sharply after Fed Meeting

As expected, the decision on the interest rate had a powerful impact on the markets. Thus, the euro/US dollar pair lost more than 100 pp in just a couple of hours and updated its recent low at 1.0630,


Oil Analysis: Finally, A Bearish Reversal?

The policy of OPEC+ countries to voluntarily reduce oil production was one of the drivers thanks to which the price of WTI oil increased by approximately 40% from its low in June. In such cases, it is appropriate to use


Central Bank Week Shakes Up Gold Market

Yesterday, the main event of the week took place — the Federal Reserve meeting, which had a noticeable impact on the market of assets denominated in US dollars. But besides the Fed meeting, there are a number of other events this

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 60% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.